Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 12/03/2012
PIL Zometa 4mg/5ml Concentrate for Solution for Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 21/09/2011 and displayed until 12/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to Further Information section
Updated on 25/07/2011 and displayed until 21/09/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 08/03/2010 and displayed until 25/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 23/09/2009 and displayed until 08/03/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/09/2008 and displayed until 23/09/2009
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
Updated on 14/12/2007 and displayed until 12/09/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to instructions about overdose
Updated on 14/08/2007 and displayed until 14/12/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 03/01/2007 and displayed until 14/08/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/04/2005 and displayed until 03/01/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 23/12/2004 and displayed until 11/04/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 22/04/2004 and displayed until 23/12/2004
Reasons for adding or updating:
  • Change to date of revision
Updated on 03/03/2004 and displayed until 22/04/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  zoledronic acid